Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differences in the mutational landscape of clonal hematopoiesis of indeterminate potential among races and between male and female patients with cancer.

Experimental hematology - 1 Oct 2024

Dhuri Kanaka, Alachkar Houda

Abstract excerpt

Clonal hematopoiesis of indeterminate potential (CHIP) has emerged as a significant precursor to hematological malignancies and is associated with several age-related diseases. We leveraged public data to explore differences in the mutational landscape of CHIP between males (Ms) and females (Fs) and across diverse racial populations. DNA (cytosine-5) methyltransferase 3 alpha (DNMT3A) mutations were substantially...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Clonal Hematopoiesis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Methyltransferase 3A

Share to Multiple Myeloma Research and Treatments

Share to Mutation

Share to Myeloproliferative Neoplasms: Diagnosis and Treatment

Share to Neoplasms

Source

Identifiers

PMID: 38969020
DOI: 10.1016/j.exphem.2024.104271

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differences in the mutational landscape of clonal hematopoiesis of indeterminate potential among races and between male and female patients with cancer.PMID 38969020Read ↗

Clonal hematopoiesis of indeterminate potential: a multisystem hub bridging hematopoietic dysfunction with non-hematopoietic diseases.Semantic proximity Read ↗

Genomic and phenomic landscape of clonal hematopoiesis in over a million ancestrally diverse participantsSemantic proximity Read ↗

Clonal hematopoiesis of indeterminate potential (CHIP): Linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease.Semantic proximity Read ↗

Risk factors for clonal hematopoiesis of indeterminate potential and mosaic chromosomal alterations.Semantic proximity Read ↗

Exome sequencing of 628,388 individuals identifies common and rare variant associations with clonal hematopoiesis phenotypesSemantic proximity Read ↗

Ancestry-dependent patterns of somatic mosaicism and clonal hematopoiesis mutations in over 125,000 individuals reveal distinct cancer associations.Semantic proximity Read ↗

Defining clonal hematopoiesis of indeterminate potential: evolutionary dynamics and detection under aging and inflammation.Semantic proximity Read ↗

Population-Based Identification of Clonal Hematopoiesis Using Peripheral Blood Whole-Genome Sequencing in Japan.Semantic proximity Read ↗

Clinical, Mutational, and Transcriptomic Characteristics in Elderly Korean Individuals With Clonal Hematopoiesis Driver Mutations.Semantic proximity Read ↗

Clinical relevance of clonal hematopoiesis in persons aged ≥80 years.Semantic proximity Read ↗

Single-cell transcriptome analyses reveal distinct gene expression signatures of severe COVID-19 in the presence of clonal hematopoiesis.Semantic proximity Read ↗

Peripheral blood somatic mosaicism and clonal hematopoiesis across ancestry backgroundsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.